Tag Archives: Fosun suture
“Made in China,” Yi Xie market need to break the three bottleneck
Although the rapid development of China\\ s medical device industry, prospects, but experts believe that if China\\ s medical device companies can not break through the current development of some of the bottlenecks will be opportunities for economic development. According to the statistical report, in the next few years, global medical device market will be 4% to 6% growth in 2011, the global medical equipment market will reach $ 312 billion. China\\ s medical device market in 2010, topped 100 billion yuan, becoming the world\\ s second largest after the U.S. medical device market.
First, the number of medical device companies, small scale, weak competitiveness
And China\\ s pharmaceutical industry is similar to China\\ s medical device industry, there are number of small scale, industry concentration is low, inadequate investment in research, innovation, low problem. Jiang Feng said that although the number of medical device companies are more, but ninety percent of small businesses, selling billions of dollars of business a few, most companies can only survive in the market for low-end, or to provide spare parts for foreign companies .
Experts believe that the medical device industry is a multi-disciplinary, knowledge-intensive, capital-intensive high-tech industries, high barriers to entry, our businesses must be talent, capital, technology, management, reinforce their own strength, can stand in the competition position.
Second, the domestic medical equipment is not high tech, high-end market occupied by foreign companies
Statistics show that China-made high-end medical device market share in less than 1 / 3, the product life and product quality with the foreign companies have a certain gap. From 2010, China\\ s medical device market, the basic composition, high-end products make up only 25%, while the low-end products accounted for 75%. The other hand, the international medical device market, the high-end products are generally accounted for 55% of the share of low-end products make up only 45%. Although China\\ s one-time supplies, dental materials, wheelchairs, medical supplies and surgical dressings and other products popular and dependable capacity ranks first in the world, but there is no doubt that these products are low value-added, high energy-consuming products.
Chinese Medicines and Health Products Import and Export Chamber of Commerce, said medical director Cai Tianzhi, and foreign medical device companies, domestic medical device companies vulnerable obvious. For CT equipment, for example, in 2010 GE, Siemens, Philips, Toshiba, Neusoft and five companies account for the domestic market share up to 92%; MRI equipment, GE, Siemens, Philips three occupy more than 50% domestic market share .
Third, the shortage of funds, and financing difficulties
Jiang Feng said China\\ s medical device companies less physical capital, asset less, causing a serious shortage of R & D investment, accounting for only 3%. Within the main source of domestic finance companies, especially small and medium private enterprises apply for grants and loans more difficult, basically there are no other financial support for science and technology. VCs are also a lot of problems, such as the PE-based, short-sighted behavior, mostly oriented rather than technology-oriented market; lack of real venture and angel capital; single exit channel, resulting in extensive use for gambling strategy, corporate executives overwhelmed, poor sustainability performance, reduce R & D and other long-term investment.
Therefore, experts suggest that, in order to guide the Ministry of Science and Innovation Fund to mobilize social capital to participate in the establishment of professional industry fund independent projects with the Ministry of Science and matched to support business innovation and development. At the same time, recommended the establishment of specialized medical equipment results into evaluation platform, with the financial services technology. In addition, local governments and Technology Park should support leading enterprises in the field of mergers and acquisitions, and promote the formation of industrial clusters.
Medical Devices extend to the multi-
Medical device market will diversify product mix. In recent years, with economic development, people\\ s lives become more affluent, the nation\\ s demands for the quality of their own health is also increasing the demand for increasingly diversified medical device, which promote medical products in China gradually extended to the multi-direction, the product structure constantly adjust the market is expanding, the market will be large numbers of home-based, portable, network-based home medical electronics equipment product.
Multinational companies to enter the domestic market accelerated. In order to further expand the potential of the huge Chinese market, take advantage of China\\ s labor resources, multinational companies will set up production bases in China to increase research and development institutions, in order to achieve the development, production and sales of local integrated operation. Such as, GE has been set up in Shanghai and Beijing production, R & D institutions, in our whole field of high-end medical equipment market share of about 50%. Siemens, Philips, Toshiba and other companies are also increasing investment in China, in addition to high-end Chinese medical device market competition, but also some rather trying to expand the potential of low-end market. Jiang Feng believes that with the Chinese medical device market, the further development of multinationals will further increase investment in the Chinese market will be through mergers, direct factories, means of further expanding the product line for the domestic market share, China\\ s various types Medical companies will face huge challenges.
Foreign capital will further enter the Chinese market. At present, more and more difficult in new drug development, cost, and cycle continues to improve, extend, continue in the latter part of the drug failed clinical trials, for the health industry, investors and operators are beginning to focus into the field of medical devices, quality resources in a battle of medical devices are quietly set off the wave of mergers and consolidation, medical diagnostic technology and services are becoming a hot investment and mergers and acquisitions.
Medical device market ushered in a favorable development opportunities
China\\ s medical device market has developed rapidly in recent years. According to the China Medical Device Industry Association statistics, the end of 2010, China\\ s medical equipment related to the number of over 14,000 enterprises, of which 99% of non-public economy type. Medical device industry sales in recent years, the average growth rate of more than 20%. In particular, low-end medical devices in a variety of products (such as sanitary materials, disposable hospital supplies, infusion, B-, ventilator, general surgical instruments like surgical instruments and laser, etc.), China\\ s output ranks first in the world.
Increased demand in emerging markets, reducing the need for hospitalization and the arrival of aging society, but also to the domestic medical equipment industry provide a strong impetus.
Cf international medical device market, China\\ s medical device industry still have a huge space. Ministry of Science and medical device industry technology innovation strategic alliance chairman, China Medical Device Industry Association vice president Jiang Feng said that in developed countries, the output value associated with the health industry accounted for 8% -15% of GDP, while China accounted for only 2% ; equipment and drugs in the market share, the developed countries of about 1:1, 1:3 in China, accounting for less than equipment; in the global market share, 72% of U.S. and Japanese Alder, China accounted for only 5%; domestic market share, the developed countries accounted for 70%, China 30%.
Technological progress and upgrading of equipment, but also will bring to market demand. Analysis of industry experts, along with technological progress, China\\ s medical device product structure will be adjusted, medical device functions from a simple diagnosis, treatment, laboratory-based to diagnosis, treatment, testing, analysis, rehabilitation, physical therapy, massage, health and other multi- extension of medical devices will continue to adjust product structure, so the market continues to expand. Meanwhile, with the continued use of our high-tech, medical devices so that the sensitivity, applicability, early diagnosis, trace analysis, diagnosis and treatment of the specificity and efficiency, etc. has been greatly improved, which is bound to promote the early retirement of a large number of old products and trigger a new medical device market.
In addition, the next few years, China\\ s procurement of medical equipment, medical equipment will give priority to domestic procurement. According to the Ministry of Health Planning and Finance Deputy Director Liu Diankui said, \"five\" will be in China during the economic means to effectively guide the medical use of domestic medical equipment. Ministry of Health\\ s focus on the current procurement projects, the successful devices are made based, in the future development of primary health care institutions in the device configuration standards and arrangements for equipment investment, it will adhere to the relatively low domestic prices as a basis for estimates of medical devices, prompting priority over domestic procurement of medical equipment.
Home medical equipment, very substantial. At present, China\\ s medical device market share of home medical equipment products is too low. According to statistics, the 2010 national total sales of home medical equipment products is only 14 billion domestic medical equipment market, accounting for only 14% of total sales, while in foreign countries this proportion is generally about 25%. Thus, home medical equipment products in China is still a huge space for development.
the developed to provide human tactile feel digital device fingertips
University at Buffalo Virtual Reality Laboratory scientists have developed a "finger digital device", worn on the index finger, the user as long as Zhiyi Zhi, Move your finger, you can replace the mouse and keyboard input devices will be information , the control computer and electronic products. It can be used in future medical, computer and computer games.
This device is equipped with three sensors, it has a wide range of functions. Among them, the position sensor to track the digital control of three-dimensional space, and to be informed of its direction of motion. Accelerometer can measure its speed. Fingertip force sensor measures the pressure.
Sensors to obtain information sent to the computer software system, if the user Move your fingers, this system will be through the acceleration and location data to track it. If the user touches the object a week, combined with the action force feedback data, we can determine the shape of the object. This issue also know that even the user s finger is caught in a knock or a table or a bomb.
In the human skin surface, the distribution of numerous temperature, touch, pressure sensation, and pain receptors (sensory nerve endings). In an interview with the surrounding environment of these receptors after stimulation through the sensory nerve, the information transmission of the central nervous system that allows us to detect changes in the environment, perception of stimuli in nature, and accordingly respond appropriately.
Currently, this invention has been patented, is expected to be put on the market within three years.
Australian scientists claim breast cancer may be transmitted through sexual and bath
University of New South Wales, a researcher said, cancer may be sexually transmitted. Breast cancer in Australian women he found the same virus that causes cervical cancer.
Survey: Nearly half of women with breast cancer are caused by cervical cancer virus
University of New South Wales, Professor Emeritus James Lawson and his colleagues published an analysis of the results for DNA and found that 50 of 24 breast cancer samples was HPV type 18, indicating that breast cancer patients has lead to cervical cancer of the same virus.
Lawson said that the human papilloma virus may be spread through sexual intercourse or bathing, the virus from the genital area may be transported through the pipe nipple into the breast. Of course, the bath of human papilloma virus can also spread out. However, human papilloma virus cause breast cancer or breast cancer patients are more susceptible to the virus also requires more research.
Example: a young female patients are more dangerous
Lawson pointed out in the paper, a review of research relevant information in 2005 show that on average, human papilloma virus infection in patients with breast cancer than those not infected with the virus tests show about a young 8-year-old patients. He said that this increases the credibility of communication theory, because the human papilloma virus in younger women, who more common, and women older than they are more likely to have multiple sexual partners.
Treatment: anti-cervical cancer vaccine?
Lawson said that if the human papilloma virus really cause breast cancer and cervical cancer, "Australian of the Year" invented by Professor Ian Frazer s cervical cancer vaccine should be able to reduce the breast cancer rate. Lawson said he is currently working on a study on research in this area.
Question: is still a lack of credible evidence
But there are 81 Swiss women scientists do the research, and found no human papilloma virus causes breast cancer evidence. Cancer Council Australia, Professor Lord Xiaoerwo said: "At present we only have some small studies have shown that human papilloma virus and there is a link between breast cancer, but researchers did not give evidence of a causal relationship between them and I think that needs further study, find more convincing evidence. "
United States found that super human form of the enzyme can enhance the cancer fighting ability
U.S. researchers found that, Akt1 enzyme has a "super" form, it can extend the life span of dendritic cells, to enhance the role of anti-cancer effect, but scientists have always thought that dendritic cells are the immune system to promote with anti- cancer, the ability of T cells responding to the main "switch." The study results were published in a recent issue of "Nature Biotechnology •" magazine.
Research project leader, Associate Professor of Immunology, Baylor College of Medicine United States, David • Dr. Spencer said: "By extending the life of dendritic cells, can prolong the activation of the human body, people need to promote the immune response." He believes that : "Dendritic cells are the immune system s main switch to pathogens or cancer, they decide to adopt a strong immune response, immune response or to ease."
Through a variety of complex experiments, Spencer and colleagues found that, Akt1 enzyme for the survival of dendritic cells has a very important role. Immediately, they found a more efficient enzyme Akt1 form. The form of the enzyme Akt1 could enable the dendritic cells to live longer, boosting immune response.
In order to obtain a new form of Akt1 enzyme, the researchers first Akt1 enzyme modified so that they can lock the plasma membrane signal is issued on a special position, so that Akt1 enzyme would have a more explicit behavior. Then, they then Akt1 inhibition of the enzyme molecule in a small part removed. Spencer said that after transformation, was the "super" Akt1 enzyme more effective.
Access to "super" Akt1 enzyme, the researchers used specially designed to feed into the adenovirus dendritic cells. "Like as had been expected, both in the laboratory or in the mice, these dendritic cells lived longer, and more effective." Spencer said, "It led to the mice have some very aggressive tumors are eliminated. "
In the laboratory, the researchers also found that "super" Akt1 enzyme on human dendritic cells equally effective, but they have not be used for the treatment of human diseases. Spencer hopes for human Akt1 enzyme when the first objective is prostate cancer, because it is their laboratory has long been a subject of study. He also said that after modification, Akt1 enzyme can also be used to address other types of cancer.
China to upgrade high-end medical service competition
In recent years, China s medical services market continues to expand, but lagging behind the development of private medical institutions, the overall level of medical services at a low level, high-end domestic market demand for medical services for gradual growth. Growth in demand from: rich people made new demands for medical services, the rise of medical tourism, and high-end medical insurance products richer and richer. "Multi-physician practice" policy, the foreign policy of the capital investment in medical institutions, also help to reduce barriers to development of the industry.
Currently, China s high-end medical services primarily through three channels: high-end general hospitals (clinics), high-end specialty hospitals (clinics) and high-end services in public hospitals. In the general hospital industry, Shanghai, Beijing and Guangzhou city has 29 brands, hundreds of high-end medical institutions. 90% of joint venture / joint venture. Many of them share the resources of the hospital doctors in public hospitals, public hospitals and medical institutions entrusted the management of foreign high-end services. High-end specialty hospitals is relatively low threshold, especially ophthalmology, dentistry, women and children s hospital in the country is developing rapidly. However, faced with inadequate resources experts, these three hospitals than public hospitals, doctors rely on resources. The development of high-end services in public hospitals first, and in various forms – cadres of health care, international services, general medical and other special needs, however, shared with the general medical physician resources, but also from the "meet the special needs" to simple "high-end, high charges "attracted a lot of controversy.
The development of high-end medical services is showing two trends: First, market competition, foreign medical groups to speed up expansion in China, some foreign companies to enter the market through the acquisition of the domestic pharmaceutical and medical-related companies have begun to enter the high number of private medical institutions end of the trend is clearly, local governments are also actively building high-end medical industrial park, stripping in public hospitals special needs services, high-end services business is expected to further expand; Second, clients and content diversity, domestic high-end target of medical institutions foreigners working groups from the domestic to domestic high-end crowd, high in the general hospital on an outpatient basis, the establishment of the maternity, cancer treatment center and other features, more professional.
To the professional development of high-end medical, oncology, cardiovascular, and other high-end medical rehabilitation hospital has potential. Medical resources is still a scarce resource, with high-end medical industry, high-end medical diverted public health care resources may be growing phenomenon, on the one hand the social and medical institutions through two channels, internal medical talents to strengthen the high-end, a in cooperation with the introduction of foreign medical institutions overseas physician resources. Moreover, to avoid the high end of public hospitals, private hospitals should be encouraged to develop, to meet the market demand for high-end medical
Growth Seminar help primary care hospital
November 25, by the good doctor medical education center, Beijing Union Medical College Hospital, Orthopaedic, Beijing Union Medical College Hospital Emergency Department, Peking University People s Hospital Heart Center, Department of Neurology, Beijing Tiantan Hospital, co-sponsored the "growth and development of hospital disciplines," Seminar in Beijing.
Currently, the majority of the district level, in part, to the municipal hospital services, medical resources are relatively weak 70% of the population of China is the backbone of the national health care system. However, a long time, this part of the hospital s infrastructure and capacity building has not received enough attention. 2011, the national health system will give priority to construction and development of county-level hospitals as a priority, which is the core capacity building specialist. Thus, the subject building has been elevated to a certain degree of strategic height.
It is understood that this training course designed to build the depth of the topics around the subject of training, the majority of growth for the backbone and the hospital managers to provide advanced academic and practical, ongoing training disciplines.
Nine chaos exposure medical fees charged standard price difficult to manage lag
From April this year, Guangxi carried out inspection of medical and health services, prices, uncovered a total of 558 cases of illegal price, the amount of alleged illegal price $ 340 million, has more than 300 million economic sanctions. Inspectors found that medical and health services mainly in the nine aspects of these problems exist because the medical fee policies, and there are all kinds, plus there are a number of medical institutions, income generation, the idea due to increased unit effectiveness.
Nine health issue fee deposit
According to reports, these nine questions are:
Recurring charges.
Price regulations, all surgical equipment and consumables needed in conventional pricing has been included in the cost of surgery, are not separately priced; Also in the \"excluded content\", \"description\" in the clear can be subject to the special price of foreign medical supplies and materials such as the name of the project, other projects are not included in the charges and materials are not allowed. Can be part of the medical units still charge these fees.
Expand the range of charges.
Part of the medical institutions to collect all newborn babies born in the radiation emergency treatment fees, infant and child health medical examinations, neonatal scale inspection, health counseling and other expenses; health advisory fees charged to patients, health education and disease costs, daily living skills assessment and Conductive Education training and other expenses.
Self-reliance project fees.
Such as CT scans of patients to receive the image recording fee, CT laser sheet fee; to collect disposable plastic potty patients, health kits, hygiene sets of cups, the patient identification card, the cost of materials (network maintenance) and other items.
Implementation has not reduced the price of medical services.
Autonomous Price Bureau has lowered subcutaneous injection, intradermal injection, intravenous injection, venous blood, venous blood and other parts of the price of medical services, but some medical institutions according to the former standard charges.
Price higher than the government set prices.
Some medical institutions outside government pricing, raising the standard charge to the patient. Such as patient check-pregnant women receive fetal electrocardiogram costs 22.2 yuan / times, the required standard of 20 yuan / times; community patients, B-routine examination requirements of 24 yuan / part time, it has charged 30 yuan / parts; of patients receive safe catheter was 35.1 yuan / branch, the provisions of 25.32 yuan / support.
Service charges are not only less service.
Some hospital patients to receive \"special treatment by endoscopy,\" \"special treatment by colonoscopy\", X-ray computed tomography (CT) scan (three-dimensional reconstruction) and conventional susceptibility testing and other expenses, but did not provide to patients medical services; on the occasion of hospital emergency patients received consultation fees, but did not actually carry out inter-hospital consultation; on routine ECG of patients do not charge for services rendered in accordance with the provisions of additional ECG leads fees.
Exceeds the rate of price increase fees charged for medical supplies.
Autonomous individual medical institution violates the relevant provisions of the Price Bureau, collected over a one-time price increase rate of medical materials fee.
Inflated the number of arbitrary charges in disguise.
Individual health care institutions in order to avoid inspection, a more subtle and sophisticated means more charges in disguise, in order to reduce medical waste material, to make up for economic losses as an excuse to hospital, in a one-time supplies, medicines, blood products, etc. make a big fuss, making a one-time consumables sales number greater than supply; blood products sales volume greater than the number of databases; drug sales amount greater than the number of libraries.
Management of medical units of the charges are still irregularities in the office.
According to reports, price departments at all levels of medical institutions in recent years, although the specification of continuous rectification, the hospital in charge of publicity, price tag has been more standardized, but upon inspection there are still shortcomings, such as some medical institutions publicity hospital drug prices contents of a single card, coverage is small, prices are not up to date, so that these patients can not fully understand the relevant information on the price charged.
Four main reasons why so difficult to regulate health services charges
Check the price of health services every year, every year some of the problems even check every year. In this regard, the inspectors believe that the main effect by the four main reasons why so difficult to regulate medical and health services fees.
Inspectors analysis, primarily because of some sense of medical and health institutions system, some unit leaders on the management fee not pay enough attention, lack of full price management personnel, or personnel without professional training fees, resulting in individual health care institutions and medical services for pharmaceuticals price policy not know much about, not through understanding.
Followed by medical and health institutions is lagging behind prices management. Medical technology is changing rapidly, making the new health care project is gradually increasing. However, due to poor management of the hospital, did not apply in time to report new medical projects, but projects with reference to other medical charges.
The third reason is the lack of financial allocations, the hospital medical institutions to enhance the software and hardware level and improve employee benefits, only the price issue, through to prescription, over-inspection, light ill treatment, with the high price of drugs and treatment and other means more charges in disguise, leading to high medical costs borne by patients, the burden is too heavy, although improving the economic efficiency of this unit, but also caused tension between patient, doctor-patient conflicts increase.
The fourth reason is because health care institutions driven by profit.
Of the top ten mobile medical forecast future market
In the past three years, InMedica, Juniper, Chilmark, ABI, In-Stat, IDC and other research companies have been in Manhattan predict the future development of mobile health services and the ultimate size of the issue proceeds. This collection of writing a top ten telemedicine predict the next five years, including forecasts for consumers and businesses, the following has been achieved from the first start of the forecast.
2012 81% of physicians use smartphones
Manhattan Institute predicts that by 2012, 81 percent of physicians will have a smart phone. Manhattan Institute\\ s May 2011 report, this figure has been achieved in 2011. The original 2010 forecast from a \"pulse\" of the report, which doctors use a variety of information technology on the rate for the follow-up survey. In 2001, only 30 percent of physicians use smartphones by 2009 about 64 percent of doctors. Doctors use the growth rate of the smart phones than the U.S. adults use the growth rate of the smart phone, U.S. adults use smart phones compared to only 30%.
The remote patient monitoring in 2014 will reach $ 1.9 billion revenue
2010 Juniper Research report \"mobile medical opportunities: 2010 to 2014 monitoring, medical applications, and mobile strategy,\" said, on a global scale, the use of remote network monitoring services to provide patient revenue in 2014 will reach $ 1.9 billion. Juniper Research forecast made is not the first to address the mobile medical industry development opportunities of the next four years forecast, but the forecasts and other projections, the industry narrowed down to a remote patient monitoring a specific service.
2014 medical enterprise mobile applications market will reach $ 1.7 billion
According to Chilmark Research\\ s November 2010 report, the medical enterprise mobile applications market is currently $ 100 million. The rapid development of mobile devices, increasing demand for doctors, medical companies need to improve quality of care and efficiency in the case, Chilmark Research predicts that within the next three years, medical mobile applications market will reach $ 1.7 billion. Chilmark core concern of the report is the EHR, CPOE, eRx, CDS and other acquisition costs associated with medical companies HIS enterprise mobile medical procedures. Chilmark forecast, for those who not only want to meet meaningful use requirements, the implementation of pay reform, but also to improve internal work processes, improve efficiency of healthcare businesses, such procedures will be different from the rest of the industry they are the biggest competitive advantage.
2016 medical wireless network market will reach $ 1.3 billion
According to market research firm ABI said in a report to the 2016 wireless network medical services market will reach $ 1.34 billion. The report, \"professional medical wireless technology,\" the report surveys the world\\ s wireless network hardware and services market size. ABI noted that the wireless Internet telephony and real-time location systems (RTLS) and will use mobile monitoring equipment in the wireless network \"medical local area network (MBAN)\" connected to each other. In fact, in 2016 approximately 30 million units expected medical MBAN equipment worldwide shipping. The report also covers the growing consumption of embedded wireless network equipment market, the market will be moving in the direction of professional development.
2016 100M wearable wireless sensors will exceed 100 million units
ABI Research published this summer in a research report that in 2016 the market demand can be worn equipment will exceed 100 million units.
Published in June last year, according to ABI Research report is expected in the future there will be 80 million such devices as fitness sensors.
ABI predicts that in the next five years, consumers in the sports, fitness and the clinical use of heart rate monitors and blood pressure monitors and other equipment will be worn for wireless sensor applications. Bluetooth 4.0 and other new low-power wireless technology will also work with social networks and smart phones to promote a combination of wireless sensor applications.
2013 blood pressure monitor shipments will reach 50 million units
In 2009, about the use of telemedicine 50,000 blood pressure, but the device shipments in 2013 will reach 50 million units. In addition, according to the 2010 InMedica reported in the world, the use of telemedicine home blood glucose meter, blood pressure monitors, weight scales, pulse oximeters and peak flow meters and other devices combined shipments will grow to 160 million units.
2013, the medical hub shipments will reach 40 million units, which will allow remote medical equipment in 2013 the total shipments of 200 million units. InMedica that the current use of the remote home medical equipment commonly used in the management of chronic diseases, especially chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), hypertension and diabetes. The study claims that the application of telemedicine has not become mainstream.
Wireless health care market in 2014 will reach $ 950 million
ABI Research\\ s 2009 report noted that health care providers to report data to the condition of wireless equipment compound annual growth rate (CAGR) to reach 77% by 2014 will generate $ 950 million global revenue.
ABI Research vice president StanSchatt in a press release that will use wireless technology to medical equipment generates costs, which is the industry a \"major obstacle.\" Interestingly, ABI press release said, \"Although health care is a global wireless market, but the cost of the equipment that most of the activities which are currently conducted in the United States.\"
2014, the medical industry will have $ 4.5 billion for wireless data
2010 In-Stat\\ s report pointed out that in 2014 the U.S. health care industry for wireless data will cost more than $ 4.5 billion. In-Stat\\ s wireless medical applications cited a number of cases, in these cases, an increase of wireless data wireless medical cost: nursing staff to obtain data, coordinating care, verify patient identification, delivery service fees, interest in the prevention of medical errors .
In early 2010, CSMG companies on the U.S. market for wireless medical income made a similar prediction. However, CSMG market forecasting services is much broader: monitoring, personal emergency assistance services (PERS), telemedicine, mobile medical equipment, mobile medical information, radio frequency identification (RFID) tracking, and health / fitness software. CSMG forecast, these services will exceed 2014 revenues $ 4.6 billion.
2011, 14% of smartphone users will use mobile medical program
IDC research firm that in 2011, about 14 percent of U.S. adults will use the mobile health care program management, health and chronic disease. Why? \"The flow of immigration has accelerated this trend in the industry to a new mode of delivery and compensation for changes in the process of health care reform will these methods become more important.\" IDC predicted in a 2011 report said.
The judge is not unrealistic, especially considering a recent Pew survey, the survey has 9% of U.S. adults use mobile medical procedures to track or manage their own health problems.
2014 M2M devices will reach 412 million units
Juniper Research analyst AnthonyCox UK in 2010, a report that the 2014 World Machine to Machine (M2M) embedded devices will increase to approximately 412 million units. Cox pointed out that this figure \"is just tip of the iceberg of the future great development potential.\" Doubt in his blog article, M2M will achieve over the next 50 billion wireless connection. Although only the M2M market, including any embedded objects, mobile SIM card (including mobile phone), Cox believes the health care market in the next few years have seen rapid growth. \"At present, the smallest mobile M2M market is likely that there is the fastest growing M2M opportunities,\" Cox wrote, \"Although in the medical market, creating a dynamic program for mobile M2M market will face many obstacles, but because life itself may depend on in these programs, future population growth in the mobile medical monitoring can ensure there is a huge market. \"
Telemedicine Gateway in 2014 will reach 100 million
IMS Research\\ s medical research department InMedica2010, a report that the 2014 uses telemedicine gateway to over 1 million, will reach 3.6 million by 2018. Although there is no specific definition of what InMedica is the \"gateway\" to connect the medical consulting firm TimGee held in Boston in 2009 connected with medical-related activities described in the wireless LAN and the gateway\\ s speech pointed out that there are two major networks are now off:
One is the gateway device (mobile), the other is a fixed wireless gateway hub, also known as bridge. Mode in the gateway device, the patient may be carrying equipment phones, smart phones, electronic diaries (PDA) or just a wireless activation device. The device can be connected to the hospital\\ s wireless network, wireless LAN or carrier networks. On the bridge, the gateway is fixed, much like the structure of the wireless access point. Patients walk in the hospital, his wireless sensors transmit data to a variety of sensors on.
New Glaucoma Treatment Device
Pathogenesis of glaucoma is more complex. Glaucoma mainly with the \"aqueous\" (the eye in a physiological fluid) drainage channels blocked, causing pressure inside the eye. Reduce intraocular pressure and accelerate the excretion of aqueous humor is key foreign medical device manufacturers to develop new products.
American manufacturers have recently developed an innovative market of \"implantable medical devices lower intraocular pressure,\" a new product – AquaFlow. According to reports, the product of implantable micro-device products, systems with high absorbent material made of collagen, specifically for the treatment of disease the largest number of \"open-angle glaucoma.\" AquaFlow appearance much like a miniature cylindrical, general surgery by an ophthalmologist to be implanted in the sclera in glaucoma patients, it can slowly absorb the eye too much room to enable the intraocular pressure returned to normal water. Even better, AquaFlow once that do not have to remove the implant because it is made with a collagen substance can be absorbed eye tissue, will not adversely affect the eye. It is understood, AquaFlow so far the world\\ s only implantable glaucoma treatment equipment products.
U S scientists are expected to be developed independently the surgical robot
According to foreign media reports, U.S. scientists announced the development of lesions and found that self-sampling of the robot, the robot independently surgery to achieve in the near future.
According to reports, developed by the Duke University this surgical robot to assist humans in the absence of any case, in a simulated artificial human organs found in the diseased tissue, and then boot device to reach the lesion, and at the same time the lesion sampling.
Scientists, this has been nicknamed Biopsy Bot robot using ultrasound to locate the system as the \"eye\" Once the lesion, it will be drawn according to their position 3-dimensional data analysis, and the \"arm\" and \"finger \"operation command issued.
Currently Biopsy Bot test success rate has been as high as 93%, and all its components are based on existing technology on the market are made, so its application is very high. The researchers believe that with further development of technology, robots will one day be independently many simple surgery.